查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1643507

医疗图像成像人工智慧的全球市场

Artificial Intelligence in Medical Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球医疗图像人工智慧市场预计将达到 81 亿美元

2024 年全球医疗图像人工智慧市场规模估计为 15 亿美元，预计 2030 年将达到 81 亿美元，2024-2030 年分析期间内的复合年增长率为 32.9%。深度学习技术是该报告分析的领域之一，预计到分析期结束时复合年增长率将达到 30.1%，达到 42 亿美元。预计在分析期内，自然语言处理 (NLP) 技术领域的复合年增长率为 36.8%。

美国市场规模估计为 3.864 亿美元，中国市场预计复合年增长率为 31.4%

预计 2024 年美国医疗图像人工智慧市场价值将达到 3.864 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 12 亿美元，2024-2030 年分析期间的复合年增长率为 31.4%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 29.7% 和 28.8%。在欧洲，预计德国的复合年增长率约为 23.2%。

全球医疗图像人工智慧市场 - 主要趋势和驱动因素摘要

人工智慧将如何彻底改变医学影像？

人工智慧 (AI) 正在透过提高诊断准确性、简化工作流程和实现更早的疾病检测来改变医学影像。传统的成像方法通常依赖人工解释，这既耗时又容易改变。人工智慧系统透过以极快的速度和精度分析影像资料来解决这些挑战，识别出人眼可能无法注意到的异常。

在海量医学影像资料集上训练的机器学习演算法可以早期检测出癌症、心血管疾病和神经系统疾病等疾病。例如，放射学中的 AI 工具可以分析电脑断层扫描、MRI 和 X 射线，以识别肿瘤、骨折和其他异常，减少诊断错误并改善患者的治疗效果。这些工具不仅提高了护理质量，还减轻了放射科医生的负担。

人工智慧也透过分析患者特定的影像资料来预测病情进展和治疗反应，从而推动个人化医疗的进步。此功能可确保为每位患者提供最佳治疗并支持个人化的治疗策略。这样，人工智慧与医学影像诊断系统的结合正在重新定义诊断的准确性和效率的标准。

推动人工智慧在医学影像领域应用的因素有哪些？

慢性病的增加以及对早期和准确诊断的需求不断增长是人工智慧在医学影像中得到应用的主要驱动力。治疗癌症、心血管疾病、神经退化性疾病等需要及时发现有效的治疗方法。人工智慧影像工具可以为医疗保健专业人员提供所需的洞察力，以便更早诊断这些疾病，改善患者的治疗效果并降低医疗成本。

先进的诊断工具和电子健康记录产生的影像资料的快速扩大也是一个关键因素。人工智慧系统分析这些资料以发现模式和相关性，提供可提高诊断准确性的可操作见解。这种能力对于大型医疗机构尤其有价值，因为放射科医生通常面临着巨大的业务。

此外，云端运算和边缘人工智慧的进步使得医学影像解决方案更加容易取得。这些技术将使医疗保健提供者无需大量基础设施投资即可利用人工智慧主导的诊断，从而加速在包括农村和服务不足地区在内的不同医疗保健环境中采用人工智慧工具。

人工智慧能否提高医学影像的效率和可近性？

人工智慧正在透过自动化日常任务和实现远距离诊断来彻底改变医学成像的效率和可访问性。人工智慧系统透过自动化影像分割、註释和报告简化了工作流程，减少了放射科医生在重复任务上花费的时间。这种效率使放射科医生能够专注于复杂的病例，从而提高整个影像部门的工作效率。

人工智慧还透过支援远端成像和远距离诊断提高了可访问性。在缺乏专家的地区，人工智慧工具可以分析医学影像并产生诊断报告，弥补医疗保健方面的差距。这些能力在资源匮乏的环境中尤其有益，及时且准确的诊断可以挽救生命。

此外，人工智慧还可以帮助优先处理需要立即关注的影像检查，从而快速分类紧急情况。例如，人工智慧系统可以即时识别中风或肺动脉栓塞等严重病症，确保患者及时得到治疗。这些进步正在改变医学影像服务的提供方式，使其更加高效，并能为更广泛的人群所接受。

是什么推动了医学影像市场AI的成长？

医疗图像市场人工智慧的成长受到几个关键因素的推动，这些因素反映了其在医疗保健领域的变革潜力。对精准诊断和个人化医疗的不断增长的需求是一个关键驱动因素。人工智慧成像工具可提高诊断准确性、实现个人化治疗计划并满足现代医疗保健不断变化的需求。

深度学习和电脑视觉等人工智慧技术的进步正在扩展医学影像处理系统的功能。这些创新正在改善疾病的检测和表征，使人工智慧成为放射科医生和临床医生的重要工具。此外，人工智慧与 CT、MRI 和超音波等成像方式的日益融合正在推动该领域的创新。

对基于人工智慧的医疗设备的监管支持和对基于价值的医疗保健的日益关注也在推动市场成长。政府和医疗保健组织正在鼓励采用人工智慧来改善患者的治疗效果并降低成本。这些因素，加上慢性病盛行率的上升和人工智慧演算法的不断发展，正在推动医学影像领域人工智慧市场的快速成长，并将成为未来诊断和医疗保健服务进步的基石。

部分

技术（深度学习技术、自然语言处理 (NLP) 技术、其他技术）、模态（电脑断层扫描模态、 MRI 模态、 X 光模态、超音波模态、核医学模式）、应用（神经应用、呼吸和呼吸最终用途（循环系统最终用途、整形外科影像筛检最终用途、其他最终用途）

受访企业范例（总合25家值得关注的企业）

  • Advanced Micro Devices, Inc.
  • Butterfly Network, Inc.
  • Canon Medical Systems USA, Inc.
  • Digital Diagnostics
  • EchoNous, Inc.
  • Enlitic
  • Exo Imaging, Inc.
  • GE Healthcare
  • HeartFlow
  • Microsoft Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29259

Global Artificial Intelligence in Medical Imaging Market to Reach US$8.1 Billion by 2030

The global market for Artificial Intelligence in Medical Imaging estimated at US$1.5 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 32.9% over the analysis period 2024-2030. Deep Learning Technology, one of the segments analyzed in the report, is expected to record a 30.1% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Natural Language Processing (NLP) Technology segment is estimated at 36.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$386.4 Million While China is Forecast to Grow at 31.4% CAGR

The Artificial Intelligence in Medical Imaging market in the U.S. is estimated at US$386.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 31.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 29.7% and 28.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 23.2% CAGR.

Global Artificial Intelligence in Medical Imaging Market - Key Trends & Drivers Summarized

How Is AI Revolutionizing Medical Imaging Diagnostics?

Artificial Intelligence (AI) is transforming medical imaging by enhancing diagnostic accuracy, streamlining workflows, and enabling early disease detection. Traditional imaging methods often rely on manual interpretation, which can be time-consuming and prone to variability. AI-powered systems address these challenges by analyzing imaging data with exceptional speed and precision, identifying abnormalities that might be missed by human eyes.

Machine learning algorithms trained on vast datasets of medical images can detect diseases such as cancer, cardiovascular conditions, and neurological disorders at an early stage. For instance, AI tools in radiology can analyze CT scans, MRIs, and X-rays to identify tumors, fractures, and other anomalies, reducing diagnostic errors and improving patient outcomes. These tools not only enhance the quality of care but also alleviate the workload of radiologists.

AI is also enabling advancements in personalized medicine by analyzing patient-specific imaging data to predict disease progression and response to treatments. This capability supports tailored therapeutic strategies, ensuring optimal care for individual patients. The integration of AI into medical imaging systems is thus redefining the standards of precision and efficiency in diagnostics.

What Drives the Adoption of AI in Medical Imaging?

The increasing prevalence of chronic diseases and the growing demand for early and accurate diagnostics are major drivers of AI adoption in medical imaging. Conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders require timely detection for effective treatment. AI-powered imaging tools provide healthcare professionals with the insights needed to diagnose these diseases at earlier stages, improving patient outcomes and reducing healthcare costs.

The surge in imaging data generated by advanced diagnostic tools and electronic health records is another critical factor. AI systems analyze this data to uncover patterns and correlations, offering actionable insights that improve diagnostic accuracy. These capabilities are particularly valuable in large healthcare facilities, where radiologists often face overwhelming workloads.

Moreover, advancements in cloud computing and edge AI are making medical imaging solutions more accessible. These technologies enable healthcare providers to leverage AI-driven diagnostics without significant infrastructure investments, facilitating the adoption of AI tools across diverse healthcare settings, including rural and underserved areas.

Can AI Improve Efficiency and Accessibility in Medical Imaging?

AI is revolutionizing efficiency and accessibility in medical imaging by automating routine tasks and enabling remote diagnostics. AI-powered systems streamline workflows by automating image segmentation, annotation, and report generation, reducing the time radiologists spend on repetitive tasks. This efficiency allows radiologists to focus on complex cases and improves overall productivity in diagnostic imaging departments.

AI also enhances accessibility by supporting teleradiology and remote diagnostics. In areas with limited access to specialists, AI tools analyze medical images and generate diagnostic reports, bridging the gap in healthcare delivery. These capabilities are particularly beneficial in low-resource settings, where timely and accurate diagnostics can save lives.

Additionally, AI is enabling faster triage of emergency cases by prioritizing imaging studies that require immediate attention. For instance, AI systems can identify critical conditions such as strokes or pulmonary embolisms in real time, ensuring that patients receive prompt treatment. These advancements are transforming the delivery of medical imaging services, making them more efficient and accessible to a broader population.

What’s Driving the Growth of the AI in Medical Imaging Market?

The growth in the Artificial Intelligence in Medical Imaging market is driven by several key factors, reflecting its transformative potential in healthcare. The rising demand for precision diagnostics and personalized medicine is a significant growth driver. AI-powered imaging tools enhance diagnostic accuracy and enable tailored treatment plans, addressing the evolving needs of modern healthcare.

Technological advancements in AI, including deep learning and computer vision, are expanding the capabilities of medical imaging systems. These innovations improve the detection and characterization of diseases, making AI an indispensable tool for radiologists and clinicians. Furthermore, the increasing integration of AI with imaging modalities such as CT, MRI, and ultrasound is driving innovation in the field.

Regulatory support for AI-based medical devices and the growing focus on value-based care are also fueling market growth. Governments and healthcare organizations are encouraging the adoption of AI to improve patient outcomes and reduce costs. These factors, combined with the rising prevalence of chronic diseases and the continuous development of AI algorithms, are propelling the rapid growth of the AI in Medical Imaging market, positioning it as a cornerstone of future advancements in diagnostics and healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Medical Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Deep Learning Technology, Natural Language Processing (NLP) Technology, Other Technologies); Modality (CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality, Nuclear Imaging Modality); Application (Neurology Application, Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 25 Featured) -

  • Advanced Micro Devices, Inc.
  • Butterfly Network, Inc.
  • Canon Medical Systems USA, Inc.
  • Digital Diagnostics
  • EchoNous, Inc.
  • Enlitic
  • Exo Imaging, Inc.
  • GE Healthcare
  • HeartFlow
  • Microsoft Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Medical Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI Solutions for Radiology Propel Growth in Diagnostic Accuracy and Speed
    • Integration of AI in Image Analysis Expands Opportunities for Early Disease Detection
    • AI for Cancer Imaging Bodes Well for Market Growth in Oncology Diagnostics
    • AI in MRI and CT Scan Interpretation Spurs Innovations in Neurological Assessments
    • Emerging AI Tools for Cardiovascular Imaging Highlight Market Potential
    • AI-Enhanced Imaging Workflow Automation Drives Demand in Radiology Departments
    • AI-Powered 3D Imaging Solutions Expand Addressable Market for Surgical Planning
    • Demand for AI in Teleimaging Accelerates Adoption in Remote Diagnostics
    • Advancements in AI for Image Reconstruction Propel Growth in Low-Dose Imaging
    • AI for Real-Time Tumor Detection Sustains Growth in Precision Imaging Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Medical Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Deep Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Deep Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Respiratory & Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Respiratory & Pulmonary Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Orthopedics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Orthopedics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Breast Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Breast Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for CT Scan Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for CT Scan Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for MRI Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for MRI Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for X-ray Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for X-ray Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Ultrasound Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Ultrasound Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Nuclear Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Medical Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Technology - Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Technology - Percentage Breakdown of Value Sales for Deep Learning Technology, Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Application - Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Application - Percentage Breakdown of Value Sales for Respiratory & Pulmonary Application, Orthopedics Application, Cardiology Application, Breast Screening Application, Other Applications and Neurology Application for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Medical Imaging by Modality - CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Artificial Intelligence in Medical Imaging by Modality - Percentage Breakdown of Value Sales for CT Scan Modality, MRI Modality, X-ray Modality, Ultrasound Modality and Nuclear Imaging Modality for the Years 2025 & 2030

IV. COMPETITION